Study in mice examines impact of reused cooking oil on breast cancer progression

by Sharita Forrest ,University of Illinois at Urbana-ChampaignThe compounds in frying oils that are repeatedly reheated to high temperatures may trigger cell proliferation and metastases i

Updated on: April 23,2024

Study in mice examines impact of reused cooking oil on breast cancer progression

by Sharita Forrest ,University of Illinois at Urbana-ChampaignThe compounds in frying oils that are repeatedly reheated to high temperatures may trigger cell proliferation and metastases i

Updated on:April 23,2024

Billions spent on cancer research but only small percentage goes to treatment, study shows

by University of SouthamptonFunding per year by type of science (A) and proportion of funding per year by type of science (B). Credit:The Lancet Oncology(2023). DOI: 10.1016/S1470-204

Updated on: January 30,2024

Billions spent on cancer research but only small percentage goes to treatment, study shows

by University of SouthamptonFunding per year by type of science (A) and proportion of funding per year by type of science (B). Credit:The Lancet Oncology(2023). DOI: 10.1016/S1470-204

Updated on:January 30,2024

Proteogenomics analysis of high-grade gliomas offers hints on tumor evolution

byJosep Carreras Leukaemia Research InstituteGraphical abstract. Credit:Cancer Cell(2024). DOI: 10.1016/j.ccell.2024.06.004In August 2023, a team of researchers including Dr. Eduard

Updated on: July 11,2024

Proteogenomics analysis of high-grade gliomas offers hints on tumor evolution

byJosep Carreras Leukaemia Research InstituteGraphical abstract. Credit:Cancer Cell(2024). DOI: 10.1016/j.ccell.2024.06.004In August 2023, a team of researchers including Dr. Eduard

Updated on:July 11,2024

12.8 percent of unique prescribers prescribed topical antifungals in 2021

by Elana GotkineIn 2021, 12.8 percent of unique prescribers in Medicare Part D prescribed topical antifungals, with about 6.5 million topical antifungal prescriptions filled, at a total cost of $231 m

Updated on: March 22,2024

12.8 percent of unique prescribers prescribed topical antifungals in 2021

by Elana GotkineIn 2021, 12.8 percent of unique prescribers in Medicare Part D prescribed topical antifungals, with about 6.5 million topical antifungal prescriptions filled, at a total cost of $231 m

Updated on:March 22,2024

Exploring artificial general intelligence for radiation oncology

by KeAi Communications Co.Large Multimodal Foundation Models For Radiation Oncology. Credit: Chenbin LiuAn estimated 600,000 people in the United States succumb to cancer every year. Beyond surgery, c

Updated on: December 28,2023

Exploring artificial general intelligence for radiation oncology

by KeAi Communications Co.Large Multimodal Foundation Models For Radiation Oncology. Credit: Chenbin LiuAn estimated 600,000 people in the United States succumb to cancer every year. Beyond surgery, c

Updated on:December 28,2023

Breast density notification laws not effective for all women

byYale UniversityA new study suggests that state-mandated notifications on mammogram reports intended to inform women of the health risks related to breast density are not worded effectively.The

Updated on: December 20,2023

Breast density notification laws not effective for all women

byYale UniversityA new study suggests that state-mandated notifications on mammogram reports intended to inform women of the health risks related to breast density are not worded effectively.The

Updated on:December 20,2023

Women more prone to selected oesophagogastric cancer chemotherapy side-effects

byEuropean Society for Medical OncologyMen and women may need to be treated differently—at least when it comes to some types of cancer. In an analysis (1) to be presented at the ESMO 2018 Congre

Updated on: December 18,2023

Women more prone to selected oesophagogastric cancer chemotherapy side-effects

byEuropean Society for Medical OncologyMen and women may need to be treated differently—at least when it comes to some types of cancer. In an analysis (1) to be presented at the ESMO 2018 Congre

Updated on:December 18,2023

Fighting cancer with LIGHT, a novel proton accelerator for treatment

by Kristiane Bernhard-Novotny,CERNModel of the LIGHT accelerator, including treatment room. Credit: AVOCancer irradiation with hadron beams, a method to which CERN contributed by propelling carb

Updated on: January 29,2024

Fighting cancer with LIGHT, a novel proton accelerator for treatment

by Kristiane Bernhard-Novotny,CERNModel of the LIGHT accelerator, including treatment room. Credit: AVOCancer irradiation with hadron beams, a method to which CERN contributed by propelling carb

Updated on:January 29,2024

Distinct signaling pathway identified as key driver for epithelial cancer development

by Kurt Bodenmüller,University of ZurichSide section of the skin with epidermal stem cells (green) with one particular clone in red. Cell nuclei are stained in blue, the white dashed lines indic

Updated on: August 03,2024

Distinct signaling pathway identified as key driver for epithelial cancer development

by Kurt Bodenmüller,University of ZurichSide section of the skin with epidermal stem cells (green) with one particular clone in red. Cell nuclei are stained in blue, the white dashed lines indic

Updated on:August 03,2024

Discovery could lead to better treatment for leukemia

by University of Illinois at ChicagoBone marrow aspirate showing acute myeloid leukemia. Several blasts have Auer rods. Credit: WikipediaPrevious research has revealed that patients with acute my

Updated on: April 14,2024

Discovery could lead to better treatment for leukemia

by University of Illinois at ChicagoBone marrow aspirate showing acute myeloid leukemia. Several blasts have Auer rods. Credit: WikipediaPrevious research has revealed that patients with acute my

Updated on:April 14,2024

Regorafenib synergizes with TAS102 against multiple gastrointestinal cancers: Study

by Impact Journals LLCTAS102 in combination with regorafenib inhibits ERK1/2 and STAT3 signaling. Credit: 2024 Zhang et al.A new research paper waspublishedinOncotargettitled,

Updated on: July 10,2024

Regorafenib synergizes with TAS102 against multiple gastrointestinal cancers: Study

by Impact Journals LLCTAS102 in combination with regorafenib inhibits ERK1/2 and STAT3 signaling. Credit: 2024 Zhang et al.A new research paper waspublishedinOncotargettitled,

Updated on:July 10,2024

CAR-T cell researchers optimistic about future of treating blood cancers

by Kelley Luckstein,Mayo ClinicCredit: AI-generated imageSurvival outcomes using chimeric antigen receptor-T cell therapy (CAR-T cell therapy) continue to be impressive for patients with some bl

Updated on: April 09,2024

CAR-T cell researchers optimistic about future of treating blood cancers

by Kelley Luckstein,Mayo ClinicCredit: AI-generated imageSurvival outcomes using chimeric antigen receptor-T cell therapy (CAR-T cell therapy) continue to be impressive for patients with some bl

Updated on:April 09,2024